MULTI-12/K1 PEDIATRIC 80 MG / VIAL — DIN 02242529
ASCORBIC ACID (ASCORBIC ACID) 80 MG; VITAMIN A 2300 UNIT; VITAMIN D 400 UNIT; VITAMIN B1 (THIAMINE HYDROCHLORIDE) 1.2 MG; VITAMIN B2 (RIBOFLAVIN-5-PHOSPHATE) 1.4 MG; PYRIDOXINE HYDROCHLORIDE 1 MG; NICOTINAMIDE 17 MG; DEXPANTHENOL 5 MG; VITAMIN E (DL-ALPHA TOCOPHERYL ACETATE) 7 UNIT; VITAMIN K1 0.2 MG; BIOTIN 20 MCG; FOLIC ACID 140 MCG; VITAMIN B12 (VITAMIN B12) 1 MCG · SANDOZ CANADA INCORPORATED · Solution · wholesale supply in Canada
Health Canada status: MARKETED
What is MULTI-12/K1 PEDIATRIC?
MULTI-12/K1 PEDIATRIC 80 MG / VIAL contains ASCORBIC ACID (ASCORBIC ACID) 80 MG; VITAMIN A 2300 UNIT; VITAMIN D 400 UNIT; VITAMIN B1 (THIAMINE HYDROCHLORIDE) 1.2 MG; VITAMIN B2 (RIBOFLAVIN-5-PHOSPHATE) 1.4 MG; PYRIDOXINE HYDROCHLORIDE 1 MG; NICOTINAMIDE 17 MG; DEXPANTHENOL 5 MG; VITAMIN E (DL-ALPHA TOCOPHERYL ACETATE) 7 UNIT; VITAMIN K1 0.2 MG; BIOTIN 20 MCG; FOLIC ACID 140 MCG; VITAMIN B12 (VITAMIN B12) 1 MCG. It is listed in the Health Canada Drug Product Database under DIN 02242529, held by SANDOZ CANADA INCORPORATED, supplied as Solution for Intravenous administration. Health Canada currently lists it as marketed, status dated 06-Jul-2006. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 80 MG / VIAL |
|---|---|
| Dosage form | Solution |
| Route | Intravenous |
Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation, because this listing covers more than one of them.
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 02242529 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2242529 |
| Brand name | MULTI-12/K1 PEDIATRIC |
| Generic / active ingredient | ASCORBIC ACID (ASCORBIC ACID) 80 MG; VITAMIN A 2300 UNIT; VITAMIN D 400 UNIT; VITAMIN B1 (THIAMINE HYDROCHLORIDE) 1.2 MG; VITAMIN B2 (RIBOFLAVIN-5-PHOSPHATE) 1.4 MG; PYRIDOXINE HYDROCHLORIDE 1 MG; NICOTINAMIDE 17 MG; DEXPANTHENOL 5 MG; VITAMIN E (DL-ALPHA TOCOPHERYL ACETATE) 7 UNIT; VITAMIN K1 0.2 MG; BIOTIN 20 MCG; FOLIC ACID 140 MCG; VITAMIN B12 (VITAMIN B12) 1 MCG |
| Market authorization holder | SANDOZ CANADA INCORPORATED |
| Health Canada schedule | PRESCRIPTION |
| Current status | MARKETED |
| Status date | 06-Jul-2006 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.